Literature DB >> 10071920

Spatial relationships between prevalent and incident spine fractures.

J W Davis1, J S Grove, R D Wasnich, P D Ross.   

Abstract

Women with prevalent fractures have an increased risk of developing additional, incident fractures. This article examines the relation between the location of prevalent fractures within the spine and the risk of subsequent vertebral fractures. The subjects were 721 Japanese-American women of mean age 69.5 +/- 5.3 (SD) years. For the analyses, the spine was categorized into three regions: an upper region, vertebrae T3-11; a middle region, vertebrae T-12 and L-1; and a lower region, vertebrae L2-5. Initial analyses were limited to women with, at most, one prevalent fracture. Compared to women without fracture, women with a prevalent fracture had odds ratios of 2-5 for developing an incident fracture outside the prevalent region. Subsequent analyses included women with multiple prevalent fractures. Women having two or three prevalent fractures had odds ratios of 7-9 for developing an incident fracture outside the prevalent region. The results suggest that the increased fracture risk of women with prevalent fractures extends beyond nearby vertebrae, and can affect vertebrae both above and below the prevalent fracture.

Entities:  

Mesh:

Year:  1999        PMID: 10071920     DOI: 10.1016/s8756-3282(98)00176-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women.

Authors:  Aki Vainionpää; Raija Korpelainen; Juhani Leppäluoto; Timo Jämsä
Journal:  Osteoporos Int       Date:  2004-06-17       Impact factor: 4.507

2.  Transcostovertebral kyphoplasty of the mid and high thoracic spine.

Authors:  Bronek M Boszczyk; Michael Bierschneider; Stefan Hauck; Rudolf Beisse; Michael Potulski; Hans Jaksche
Journal:  Eur Spine J       Date:  2005-06-21       Impact factor: 3.134

3.  New fractures after vertebroplasty: adjacent fractures occur significantly sooner.

Authors:  A T Trout; D F Kallmes; T J Kaufmann
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

4.  Densitometric and geometric measurement of the proximal femur in elderly women with and without osteoporotic vertebral fractures by volumetric quantitative multi-slice CT.

Authors:  Sheng-yong Wu; Ji Qi; Ying Lu; Jing Lan; Jin-chao Yu; Lian-qing Wen; Zhuo-li Zhang
Journal:  J Bone Miner Metab       Date:  2010-04-06       Impact factor: 2.626

5.  A probabilistic finite element analysis of the stresses in the augmented vertebral body after vertebroplasty.

Authors:  Antonius Rohlmann; Hadi Nabil Boustani; Georg Bergmann; Thomas Zander
Journal:  Eur Spine J       Date:  2010-04-02       Impact factor: 3.134

Review 6.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

7.  Previous vertebral compression fractures add to the deterioration of the disability and quality of life after an acute compression fracture.

Authors:  Nobuyuki Suzuki; Osamu Ogikubo; Tommy Hansson
Journal:  Eur Spine J       Date:  2009-09-18       Impact factor: 3.134

8.  Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis.

Authors:  Robert Lindsay; Simon Pack; Zhengqing Li
Journal:  Osteoporos Int       Date:  2004-09-28       Impact factor: 4.507

Review 9.  Recognizing and reporting osteoporotic vertebral fractures.

Authors:  Mikayel Grigoryan; Ali Guermazi; Frank W Roemer; Pierre D Delmas; Harry K Genant
Journal:  Eur Spine J       Date:  2003-09-11       Impact factor: 3.134

Review 10.  Interdisciplinary approach to balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures.

Authors:  Helmut Franck; Bronek M Boszczyk; Michael Bierschneider; Hans Jaksche
Journal:  Eur Spine J       Date:  2003-09-12       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.